Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 74-82

  Peters, Brian M ^a   Ward, Raven M ^a,b   Rane, Hallie S ^c,d   Lee, Samuel A ^c,d   Noverr, Mairi C ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b FISK UNIVERSITY   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CATHETER LOCK SOLUTION; POLYSTYRENE; SILICONE; SODIUM 2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL 5) [(PHENYLAMINO)CARBONYL] 2H TETRAZOLIUM HYDROXIDE INNER SALT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BIOFILM; CANDIDA ALBICANS; CATHETER; CLINICAL EFFECTIVENESS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COST; DOSE RESPONSE; FUNGUS GROWTH; MICROBIAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; SAFETY; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; POLYSTYRENES; SILICONES; STAPHYLOCOCCUS AUREUS; TETRAZOLIUM SALTS;

EID: 84872029226     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01599-12     Document Type: Article

References (51)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. 2001. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345:1368-1377.
3. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW. 2005. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann. Emerg. Med. 45:524-528.
4. Kallen AJ, Patel PR, O'Grady NP. 2010. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin. Infect. Dis. 51:335-341.
5. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2:114-122.
6. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25:193-213.
7. Beathard GA. 1999. Management of bacteremia associated with tun-neled-cuffed hemodialysis catheters. J. Am. Soc. Nephrol. 10:1045-1049.
8. Lin JN, Lai CH, Chen YH, Chang LL, Lu PL, Tsai SS, Lin HL, Lin HH. 2010. Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: a matched case-control study. Acad. Emerg. Med. 17:1072-1079.
9. Onland W, Pajkrt D, Shin C, Fustar S, Rushing T, Wong WY.2011. Pediatric patients with intravascular devices: polymicrobial bloodstream infections and risk factors. J. Pathog. 2011 :826169. doi:10.4061/2011/826169.
10. Sutter D, Stagliano D, Braun L, Williams F, Arnold J, Ottolini M, Epstein J. 2008. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management. Pediatr. Infect. Dis. J. 27:400-405.
11. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
12. Shirtliff ME, Peters BM, Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299:1-8.
13. Nakazawa N. 2010. Infectious and thrombotic complications of central venous catheters. Semin. Oncol. Nurs. 26:121-131.
14. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
15. Toltzis P. 2006. Antibiotic lock technique to reduce central venous catheter-related bacteremia. Pediatr. Infect. Dis. J. 25:449-450.
16. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, Ghannoum MA. 2004. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob. Agents Chemother. 48:1727-1732.
17. Van Praagh AD, LI T, Zhang S, Arya A, Chen L, Zhang XX, Bertolami S, Mortin LI. 2011. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob. Agents Chemother. 55:4081-4089.
18. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol. Dial. Transplant. 21:2247-2255.
19. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM. 2002. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol. Dial. Transplant. 17:2189-2195.
20. Chambers ST, Peddie B, Pithie A. 2006. Ethanol disinfection of plastic-adherent micro-organisms. J. Hosp. Infect. 63:193-196.
21. Rane HS, Bernardo SM, Walraven CJ, Lee SA. 2012. In vitro analyses of ethanol activity against Candida albicans biofilms. Antimicrob. Agents Chemother. 56:4487-4489.
22. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. 2006. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect. Immun. 74:3415-3426.
23. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
24. Adam B, Baillie GS, Douglas LJ. 2002. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol. 51:344-349.
25. Croes S, Deurenberg RH, Boumans ML, Beisser PS, Neef C, Stobberingh EE. 2009. Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage. BMC Microbiol. 9:229. doi:10.1186/1471-2180-9-229.
26. Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL. 2010. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J. Vis. Exp. 44:pii=2287. doi:10.3791/2287.
27. Jurcisek JA, Dickson AC, Bruggeman ME, Bakaletz LO. 2011. In vitro biofilm formation in an 8-well chamber slide. J. Vis. Exp. 47:pii=2481. doi:10.3791/2481.
28. Donegan K, Matyac C, Seidler R, Porteous A. 1991. Evaluation of methods for sampling, recovery, and enumeration of bacteria applied to the phylloplane. Appl. Environ. Microbiol. 57:51-56.
29. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. 2007. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob. Agents Chemother. 51:78-83.
30. Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. 2010. Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol. Med. Microbiol. 59:493-503.
31. Segarra-Newnham M, Martin-Cooper EM. 2005. Antibiotic lock technique: a review of the literature. Ann. Pharmacother. 39:311-318.
32. Bleyer AJ. 2007. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin. J. Am. Soc. Nephrol. 2:1073-1078.
33. Berrington A, Gould FK. 2001. Use of antibiotic locks to treat colonized central venous catheters. J. Antimicrob. Chemother. 48:597-603.
34. Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traore O, Forestier C. 2009. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol. Dial. Transplant. 24:3204-3209.
35. Mukherjee PK, Mohamed S, Chandra J, Kuhn D, Liu S, Antar OS, Munyon R, Mitchell AP, Andes D, Chance MR, Rouabhia M, Ghannoum MA. 2006. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect. Immun. 74:3804-3816.
36. Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53:3914-3922.
37. Chiou PF, Chang CC, Wen YK, Yang Y. 2006. Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin. Nephrol. 65:419-422.
38. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. 2004. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 66:801-805.
39. Poole CV, Carlton D, Bimbo L, Allon M. 2004. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant. 19:1237-1244.
40. Dixon JJ, Steele M, Makanjuola AD. 2012. Anti-microbial locks increase the incidence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol. Dial. Transplant. 27:3575-3581.
41. McDonnell G, Russell AD. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179.
42. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. 2007. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59:401-406.
43. Blackwood RA, Klein KC, Micel LN, Willers ML, Mody RJ, Teitelbaum DH, Cober MP. 2011. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr. Infect. Dis. J. 30:1105-1107.
44. Broom J, Woods M, Allworth A, McCarthy J, Faoagali J, Macdonald S, Pithie A. 2008. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand. J. Infect. Dis. 40:399-406.
45. Crnich CJ, Halfmann JA, Crone WC, Maki DG. 2005. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect. Control Hosp. Epidemiol. 26:708-714.
46. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. 2003. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with Broviac catheter. J. Pediatr. Hematol. Oncol. 25:616-621.
47. Oliveira C, Nasr A, Brindle M, Wales PW. 2012. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 129:318-329.
48. Hawser S. 1996. Adhesion of different Candida spp. to plastic: XTT formazan determinations. J. Med. Vet. Mycol. 34:407-410.
49. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. 2004. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 48:2659-2664.
50. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
51. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50:3839-3846.